Occam Places Geoff McDonough as CEO of Generation Bio

Occam Places Geoff McDonough as CEO of Generation Bio

Generation Bio, a Casdin/Atlas investment, is a now public gene therapy company focused on providing treatment for patients living with rare, genetic diseases.

In late 2019, Occam was hired by Atlas Venture to build a complete C-level leadership team around the company’s platform. One of our placements was Geoff McDonough, MD as CEO along with a CFO who later took the company public, raising $125M in the process. Previously, McDonough served as the CEO of Swedish biopharmaceutical, Sobi, following a lengthy tenure at Genzyme.

About Occam Global

Occam Global is an executive recruiting and leadership advisory firm with specialties across technological fields including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.